Antimicrobial peptide delivery from trabecular bone grafts

Journal of Biomaterials and Tissue Engineering

Volumn 4, Issue 11, 2014, Pages 967-972

  Kazemzadeh Narbat, Mehdi ^a   Wang, Qiong ^a   Hancock, Robert E W ^a   Wang, Rizhi ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Allografts; Antimicrobial Peptides; Bone Scaffolds; Drug Delivery

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; SHORT CATIONIC ANTIMICROBIAL PEPTIDE HHC 36; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; AUTOGRAFT; BACTERIAL SURVIVAL; BONE GRAFT; BOVINAE; COLONY FORMING UNIT; DRUG DELIVERY SYSTEM; DRUG SCREENING; INFECTION RISK; NONHUMAN; SCANNING ELECTRON MICROSCOPY; TISSUE SCAFFOLD; TRABECULAR BONE; X RAY POWDER DIFFRACTION;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84921422991     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2014.1272     Document Type: Article

References (32)

1. P. V. Giannoudis, H. Dinopoulos, and E. Tsiridis, Bone substitutes: An update. Injury36, S20 (2005).
2. S. J. Hollister, Porous scaffold design for tissue engineering. Nat. Mater.4, 518 (2005).
3. U. Kneser, D. J. Schaefer, E. Polykandriotis, and R. E. Horch, Tissue engineering of bone: The reconstructive surgeon’s point of view. Journal of Cellular and Molecular Medicine10, 7 (2006).
4. J. R. Lakey, M. Mirbolooki, C. Rogers, and J. Mohr, Demand for human allograft tissue in Canada. Cell and Tissue Banking8, 31 (2007).
5. W. R. Moore, S. E. Graves, and G. I. Bain, Synthetic bone graft substitutes. Australian and New Zealand Journal of Surgery71, 354 (2001).
6. HCPUnet, Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality, http://hcupnet.ahrq.gov.
7. S. Kurtz, K. Ong, E. Lau, F. Mowat, and M. Halpern, Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. Journal of Bone and Joint Surgery-American Vo l u m e89A, 780 (2007).
8. H. S. Khanuja, J. J. Vakil, M. S. Goddard, and M. A. Mont, Cement-less femoral fixation in total hip arthroplasty. Journal of Bone and Joint Surgery-American Volume93A, 500 (2011).
9. C. Delloye, O. Cornu, V. Druez, and O. Barbier, Bone allografts-What they can offer and what they cannot. Journal of Bone and Joint Surgery-British Volume89B, 574 (2007).
10. P. S. Ko, M. K. Tio, Y. K. Tang, W. L. Tsang, and J. J. Lam, Sealing the intramedullary femoral canal with autologous bone plug in total knee arthroplasty. The Journal of Arthroplasty18, 6 (2003).
11. S. M. Jafari, C. Coyle, S. M. J. Mortazavi, P. F. Sharkey, and J. Parvizi, Revision hip arthroplasty infection is the most common cause of failure. Clinical Orthopaedics and Related Research 468, 2046 (2010)
12. J. M. Schierholz and J. Beuth, Implant infections: A haven for opportunistic bacteria. Journal of Hospital Infection 49, 87 (2001)
13. T. E. Mroz, M. J. Joyce, M. P. Steinmetz, I. H. Lieberman, and J. C. Wang, Musculoskeletal allograft risks and recalls in the United States. Journal of the American Academy of Orthopaedic Surgeons16, 559 (2008).
14. D. Campoccia, L. Montanaro, P. Speziale, and C. R. Arciola, Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials31, 6363 (2010).
15. A. W. Smith, Biofilms and antibiotic therapy: Is there a role for combating bacterial resistance by the use of novel drug delivery systems? Advanced Drug Delivery Reviews57, 1539 (2005).
16. M. Zilberman and J. J. Elsner, Antibiotic-eluting medical devices for various applications. J. Controlled Release130, 202 (2008).
17. W. A. Jiranek, A. D. Hanssen, and A. S. Greenwald, Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. Journal of Bone and Joint Surgery-American Volume88A, 2487 (2006).
18. M. Stigter, J. Bezemer, K. de Groot, and P. Layrolle, Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J. Controlled Release99, 127 (2004).
19. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Antibiotic Resistance Threats in the United States (2013).
20. K. T. Kavanagh, L. E. Calderon, D. M. Saman, and S. K. Abusalem, The use of surveillance and preventative measures for methicillin-resistant infections in surgical patients. Antimicrobial Resistance and Infection Control3, 18 (2014).
21. R. M. Klevens, M. A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L. H. Harrison, R. Lynfield, G. Dumyati, J. M. Townes, A. S. Craig, E. R. Zell, G. E. Fosheim, L. K. McDougal, R. B. Carey, and S. K. Fridkin, Invasive methicillin-resistant staphylococcus aureus infections in the United States. JAMA-Journal of the American Medical Association298, 1763 (2007).
22. K. A. Culos, J. P. Cannon, and S. A. Grim, Alternative agents to vancomycin for the treatment of methicillin-resistant staphylococcus aureus infections. American Journal of Therapeutics20, 200 (2013).
23. R. E. W. Hancock and H. G. Sahl, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol.24, 1551 (2006).
24. K. A. Brogden, Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol.3, 238 (2005).
25. C. D. Fjell, H. Jenssen, K. Hilpert, W. A. Cheung, N. Panté, R. E. W. Hancock, and A. Cherkasov, Identification of novel antibacterial peptides by chemoinformatics and machine learning. J. Med. Chem.52, 2006 (2009).
26. M. H. Ma, M. Kazemzadeh-Narbat, Y. Hui, S. S. Lu, C. F. Ding, D. D. Y. Chen, R. E. W. Hancock, and R. Wang, Local delivery of antimicrobial peptides using self-organized TiO2 nanotube arrays for peri-implant infections. Journal of Biomedical Materials Research Pa r t A100A, 278 (2012).
27. M. Kazemzadeh-Narbat, J. Kindrachuk, K. Duan, H. Jenssen, R. E. W. Hancock, and R. Z. Wang, Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials31, 9519 (2010).
28. M. Kazemzadeh-Narbat, B. F. L. Lai, C. F. Ding, J. N. Kizhakkedathu, R. E. W. Hancock, and R. Z. Wang, Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. Biomaterials34, 5969 (2013).
29. M. Kazemzadeh-Narbat, S. Noordin, B. A. Masri, D. S. Garbuz, C. P. Duncan, R. E. W. Hancock, and R. Wang, Drug release and bone growth studies of antimicrobial peptide-loaded calcium phosphate coating on titanium. Journal of Biomedical Materials Research Part B-Applied Biomaterials100B, 1344 (2012).
30. R. E. Smith and R. MacQuarrie, A sensitive fluorometric method for the determination of arginine using 9,10-phenanthrenequinone. Anal. Biochem.90, 246 (1978).
31. A. Cherkasov, K. Hilpert, H. Jenssen, C. D. Fjell, M. Waldbrook, S. C. Mullaly, R. Volkmer, and R. E. W. Hancock, Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem. Biol.4, 65 (2008).
32. G. Z. Gao, D. Lange, K. Hilpert, J. Kindrachuk, Y. Q. Zou, J. T. J. Cheng, M. Kazemzadeh-Narbat, K. Yu, R. Wang, S. K. Straus, D. E. Brooks, B. H. Chew, R. E. W. Hancock, and J. N. Kizhakkedathu, The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials32, 3899 (2011).